¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Urine Glucose reagent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • split-timed urine protein
    ½Ã°£´ëº°¿ä´Ü¹éÁ¤·®
  • urine
    ¼Òº¯, ¿ä, ¿ÀÁÜ
  • urine specimen
    ¿ä°Ëü
  • blood glucose
    Ç÷´ç
  • blood glucose monitoring
    Ç÷´ç°¨½Ã
  • glucose
    Æ÷µµ´ç, ´ç±Û·çÄÚ¿À½º
  • glucose dehydrogenase
    Æ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿Åë
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose intolerance
    Æ÷µµ´ç¸ø°ßµõ(Áõ), Æ÷µµ´çºÒ³»¼º
  • glucose lactate cycle
    Æ÷µµ´çÁ¥»ê¿°È¸·Î
  • glucose tolerance test
    ´çºÎÇϰ˻ç
  • glucose-6-phosphatase
    Æ÷µµ´çÀ°ÀλêÈ­È¿¼Ò, ±Û·çÄÚ¿À½º-6-Æ÷½ºÆÄŸ¾ÆÁ¦
  • glucose-6-phosphate dehydrogenase
    6-ÀλêÆ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • insulin-to-glucose ratio
    Àν¶¸°´ëÆ÷µµ´çºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿Åë
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose
    Æ÷µµ´ç, ±Û·çÄÚ½º
  • glucose-6-phosphatase
    Æ÷µµ´çÀ°ÀλêÈ­È¿¼Ò, ±Û·çÄÚ¿À½º-6-Æ÷½ºÆÄŸ¾ÆÁ¦
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • glucose insulin tolerance test
    Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
  • glucose tolerance test
    Æ÷µµ´ç°ßµõ°Ë»ç
  • liquid glucose
    ¾×üÆ÷µµ´ç
  • hyposthenuric urine
    ÀúÀå´¢
  • initial urine
    Ãʱⴢ, ½ÃÀÛ´¢
  • insulin-to-glucose ratio
    Àν¶¸°Æ÷µµ´çºñÀ²
  • midstream urine
    Áß°£´¢
  • milky urine
    ¾ÏÁ×´¢
  • obligatory urine volume
    Ãּұ⺻´¢·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lloyds reagent
    ·ÎÀ̵å½Ã¾à
  • Nesslers reagent
    ³×½½·¯½Ã¾à
  • Stix reagent strip test
    Stix ½Ã¾à´ë<½Ã¾àÁö>½ÃÇè
  • Trinders reagent
    Æ®¸°´õ½Ã¾à
  • analytical reagent =AR
    ºÐ¼®½Ã¾à(¡­ãËå·).
  • antiglobulin reagent, monospecific
    ´Ü°¡ Çױ۷κи° ½Ã¾à
  • arginine decarboxylase reagent
    ¾Æ¸£±â´ÑŻī¸£º¹½ÇÈ¿¼Ò<--µ¥Ä«¸£º¹½Ç¶óÁ¦
  • hydrogen peroxide reagent
    °ú»êÈ­¼ö¼Ò½Ã¾à
  • polyspecific antiglobulin reagent
    ´ÙƯÀÌÇױ۷κҸ° ½Ã¾à
  • reagent strip detection
    ½Ã¾àÁö<--´ë(Óá)>°ËÃâ
  • GOD= glucose oxidase
    Æ÷µµ´ç»êÈ­ È¿¼Ò.
  • GTT= glucose tolerance test
    ´çºÎÇÏ °Ë»ç.
  • Glucose
    ±Û·çÄÚ¿À½º
  • Glucose phosphatase
    Àλê(×òß«)±Û·çÄÚ¿À½º
  • Glucose tolerance
    ³»´ç·Â(Ò±ÓØÕô)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • catheterized urine specimen
    »ðÀÔµµ´¢°Ëü
  • clean catch midstream urine specimen
    û°áäÃë Áß°£´¢°Ëü
  • cloudy urine
    ȥŹ´¢
  • crude urine
    Èñ¹Ú´¢(ýüÚÝèñ).
  • diabetic urine
    ´ç´¢º´¼º ´¢(¡­èñ).
  • examination of urine
    ¿ä(èñ)°Ë»ç.
  • extravasation of urine
    ¿äÀ¯Ãâ.
  • hyposthenuric urine
    ÀúÀå´¢
  • incontinence of urine ³ª incontinentia urinae
    ¿ä½Ç±Ý(èñã÷Ð×).
  • initial urine
    Ãʱⴢ.
  • maple syrup urine disease
    ´Üdz´ç¹Ð´¢º´(Õ®ù£ÓØÚËèñÜ»).
  • maple syrup urine disease
    ´Üdz´ç¹Ð´¢º´(Ó¡ù£ÓØÚËÒãÜ»)
  • maple syrup urine disease
    ´Üdz ½Ã·´´¢ Áúȯ.
  • midstream urine
    Áß°£´¢
  • milky urine
    À¯¹Ì´¢(êáÚ¼èñ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucose tolerance test
    ±Û·çÄÚ½º ³»¼º °Ë»ç(Ò±àõì×í­)
  • UDP-glucose
    UDP-±Û·çÄÚ½º
  • uridine diphosphate glucose
    À¯¸®µò ÀÌÀλê(ì£×òß«) ±Û·çÄÚ½º
  • Benedict's reagent
    º£³×µñÆ® ½Ã¾à(ãËå·)
  • bifunctional reagent
    ¾ç±â´É ½Ã¾à(å»Ñ¦ÒöãËå·)
  • Coombs' reagent
    ÄñÁî ½Ã¾à(ãËå·)
  • Ehrlich's reagent
    ¿¡¸¦¸®È÷ ½Ã¾à(ãËå·)
  • Ellman's reagent
    ¿¤¸¸ ½Ã¾à (ãËå·)
  • Fenton's reagent
    ÆæÅæ ½Ã¾à (ãËå·)
  • Girard's reagent
    Áö¶óµå ½Ã¾à(ãËå·)
  • Hill reagent
    Èú ½Ã¾à(ãËå·)
  • limiting reagent
    Á¦Çѽþà(ð¤ùÚãËå·)
  • Nessle's reagent
    ³×½½·¯ ½Ã¾à(ãËå·)
  • Nylander's reagent
    ´Ò¶õ´õ½Ã¾à(ãËå·)
  • PAS reagent
    PAS ½Ã¾à(ãËå·)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RFI Renal Failure Index
           Urine Na
&nb...
PU palindromic unit; passed urine; pepsin unit; peptic ulcer; pregnancy urine; 6-propyluracil; prostati...
UC ulcerative colitis; ultracentrifugal; umbilical cord; unchanged; unclassifiable; unconscious; undiff...
ISI International Sensitivity Index of reagent/instrument combination
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
U Urine
UF Urine flow
UFR Urine flow rate
Uosm Urine osmalality
U/O Urine output
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maple syrum urine disease
    ´Üdz ³ª¹« ½Ã·´ º´
    Ãø¼â, ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê
  • maple syrup urine disease
    ´Üdz ´ç¹Ð ´¢ Áúȯ
    Ãø¼â ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê[valine, leucine, isoleucine]ÀÇ ½ÉÇÑ Áõ°¡¸¦ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÀû Ư¡Àº Á¤½Å Áöü ¹ß´Þ Áö¿¬, Æ÷À¯ °ï¶õ, ¿äÃë µîÀÌ´Ù.
  • morning urine
    ¾ÆÄ§ ´¢
  • reagent
    ½Ã¾à
    ¾î¶² ´Ù¸¥ ¹°ÁúÀ» °ËÃà, ÃøÁ¤, »ý¼ºÇϱâ À§ÇÑ Æ¯Á¤ÇÑ È­ÇÐ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Âµ¥ »ç¿ëµÇ´Â ¹°Áú.
  • residual urine
    ÀÜ´¢
  • Stix reagent strip test
    Stix ½Ã¾àÁö ½ÃÇè
  • urine analysis
    ¿ä °Ë»ç, ¼Òº¯ ºÐ¼®
    µ¿ÀǾî=urinalysis.
  • urine-mucoid
    ¿ä ¹«ÄÚÀ̵å
    ¿ä Áß¿¡¼­ º¼ ¼ö ÀÖ´Â Á¡¾× ¸ð¾çÀÇ ¹°Áú.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
incontinence of urine Inability to hold urine in the bladder. This is due to failure of voluntary control over the urinary sphincters resulting in involuntary passage of urine (wetting).
(12 Dec 1998)
oasthouse urine disease An inherited metabolic defect in the absorption of methionine which is converted by intestinal bacteria to alpha-hydroxybutyric acid; characterised by diarrhoea, tachypnea, and marked urinary excretion of alpha-hydroxybutyric acid (causing an odour like that of an oasthouse).
Origin: oast, kiln for drying hops, malt, or tobacco
(05 Mar 2000)
febrile urine Dark coloured, concentrated urine of strong odour, passed by one suffering from fever.
Synonym: feverish urine.
(05 Mar 2000)
feverish urine Dark coloured, concentrated urine of strong odour, passed by one suffering from fever.
Synonym: feverish urine.
(05 Mar 2000)
urine <physiology> In mammals, a fluid excretion from the kidneys; in birds and reptiles, a solid or semisolid excretion.
In man, the urine is a clear, transparent fluid of an amber colour and peculiar odour, with an average density of 1.02. The average amount excreted in 24 hours is from 40 to 60 ounces (about 1,200 cubic centimeters). Chemically, the urine is mainly an aqueous solution of urea, salt (sodium chloride), and uric acid, together with some hippuric acid and peculiar pigments. It usually has an acid reaction, owing to the presence of acid phosphates of soda or free uric acid. Normally, it contains about 960 parts of water to 40 parts of solid matter, and the daily average excretion is 35 grams (540 grains) of urea.75 gram (11 grains) of uric acid, and 16.5 grams (260 grains) of salt. Abnormally, it may contain sugar as in diabetes, albumen as in Bright's disease, bile pigments as in jaundice, or abnormal quantities of some one or more of the normal constituents.
Origin: F. Urine, L. Urina; akin to urinari to plunge under water, to dive, Gr. Urine; cf. Skr. Var water, Icel. R drizzling rain, AS. Waer the sea.
Source: Websters Dictionary
(01 Mar 1998)
urine catecholamine A test that measures the level of catecholamines or their metabolites in the urine. A 24 hour urine sample is necessary for this assay. Elevations may be seen in pheochromocytoma or neuroblastoma. Normal urine levels of adrenaline should be: 0.5 to 20 mcg/ml and normal urine levels of noradrenaline should be 15 to 80 mcg/ml.
(27 Sep 1997)
urine immunofixation A special laboratory technique that is used to identify specific proteins in the blood or urine. It has greatest application in the identification (and monitoring) of monoclonal proteins that are produced in conditions like Waldenstom's macroglobulinaemia and multiple myeloma.
(27 Sep 1997)
urine metanephrine A test that measures the level of catecholamines or their metabolites in the urine. A 24 hour urine sample is necessary for this assay. Elevations may be seen in pheochromocytoma or neuroblastoma. Normal urine levels of adrenaline should be: 0.5 to 20 mcg/ml and normal urine levels of noradrenaline should be 15 to 80 mcg/ml.
(27 Sep 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
Benedict-Hopkins-Cole reagent <chemistry> Magnesium glyoxalate, made from a mixture of oxalic acid and magnesium, used for testing proteins for the presence of tryptophan.
(12 Aug 2000)
biuret reagent An alkaline solution of copper sulfate.
(05 Mar 2000)
Mandelin's reagent A solution of ammonium vanadate in sulfuric acid, used in colour tests for alkaloids.
(05 Mar 2000)
reagent <technique> A histochemical technique based on periodic acid oxidation of a substance containing the 1,2-glycol grouping.
It is used for staining carbohydrates as the resulting dialdehyde reacts with Schiff reagent to form a coloured product.
The adjacent hydroxyl groups are oxidized to form aldehydes by periodic acid (HIO4) and these aldehyde groups react with Schiff's reagent (basic fuchsin decolourised by sulphurous acid) to give a purple colour.
Acronym: PAS
(18 Nov 1997)
reagent kits, diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.
(12 Dec 1998)
reagent strips Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á